Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity

v3.10.0.1
Stockholders' Equity
6 Months Ended
Jun. 30, 2018
Stockholders' Equity Note [Abstract]  
Stockholders' Equity Note Disclosure [Text Block]
Note 6 - Stockholders’ Equity
 
Stock Issuances to Fortress
 
Pursuant to the Founders Agreement, the Company issued 834,756 shares of common stock to Fortress for the Annual Stock Dividend, representing 2.5% of the fully diluted outstanding equity of the Company on March 12, 2018.
 
Stock Awards
 
Stock Options
 
The Company has in effect the 2016 Incentive Plan (the “Incentive Plan”). The Incentive Plan was adopted in 2016 by our stockholders and the compensation committee of the Company’s board of directors and is authorized to grant stock-based awards to directors, officers, employees and consultants. The plan initially authorized grants to issue up to 2,000,000 shares of authorized but unissued common stock and expires 10 years from adoption and limits the term of each option to no more than 10 years from the date of grant. In June 2018, the Company’s stockholders approved an amendment to the Incentive Plan to increase the number of authorized shares issuable by 3,000,000 shares, for a total of 5,000,000 shares. Total shares available for the issuance of stock-based awards under the Incentive Plan was 2,915,325 shares at June 30, 2018.
 
The following table summarizes stock option activities for the six months ended June 30, 2018:
 
 
 
Stock Options
 
 
Weighted Average

Exercise Price
 
 
Weighted Average

Remaining

Contractual Life (in

years)
 
Nonvested at December 31, 2017
 
 
1,241,675
 
 
$
5.73
 
 
 
9.31
 
Options granted
 
 
-
 
 
 
-
 
 
 
-
 
Options outstanding
 
 
1,241,675
 
 
 
5.73
 
 
 
8.81
 
Options vested and exercisable at June 30, 2018
 
 
285,419
 
 
$
5.73
 
 
 
8.81
 
 
As of June 30, 2018, the Company had unrecognized stock-based compensation expense related to options of $1.2 million with a weighted average vesting period of approximately 1.4 years.
 
Restricted Stock
 
The following table summarizes restricted stock award activities for the six months ended June 30, 2018:
 
 
 
Number of Shares
 
 
Weighted Average

Grant Date Fair

Value
 
Nonvested at December 31, 2017
 
 
180,000
 
 
$
5.73
 
Granted
 
 
50,000
 
 
 
7.89
 
Nonvested at June 30, 2018
 
 
230,000
 
 
$
6.20
 
 
As of June 30, 2018, the Company had unrecognized stock-based compensation expense related to restricted stock of $1.1 million with a weighted average vesting period of approximately 2.8 years.
 
Restricted Stock Units
 
During the six months ended June 30, 2018, the Company granted 379,000 restricted stock units to employees and 200,000 restricted stock units to two consultants. The grants to the employees vest over 4 years on the anniversary date of the grant. The grants to the consultants vest 50% on date of grant and the remaining 50% over 4 years on the anniversary date of the grant.
 
The following table summarizes restricted stock units activities for the six months ended June 30, 2018:
 
 
 
Number of Units
 
 
Weighted Average

Grant Date Fair

Value
 
Nonvested at December 31, 2017
 
 
134,000
 
 
$
6.53
 
Granted
 
 
579,000
 
 
 
10.82
 
Vested
 
 
(100,000
)
 
 
10.29
 
Nonvested at June 30, 2018
 
 
613,000
 
 
$
9.97
 
 
As of June 30, 2018, the Company had unrecognized stock-based compensation expense related to restricted stock units of approximately $4.0 million with a weighted average vesting period of approximately 2.0 years.
 
The following table summarizes stock-based compensation expense for the three and six months ended June 30, 2018 and 2017 (in thousands).
 
 
 
For the three months ended June 30,
 
 
For the six months ended June 30,
 
 
 
2018
 
 
2017
 
 
2018
 
 
2017
 
Employee
 
$
1,018
 
 
$
334
 
 
$
1,723
 
 
$
334
 
Non-employee
 
 
(47
)
 
 
63
 
 
 
1,243
 
 
 
63
 
Total stock-based compensation expense
 
$
971
 
 
$
397
 
 
$
2,966
 
 
$
397
 
 
Warrants
 
A summary of warrant activities for six months ended June 30, 2018 is presented below:
 
 
 
Warrants
 
 
Weighted Average

Exercise Price
 
 
Weighted Average

Remaining

Contractual Life (in

years)
 
Outstanding as of December 31, 2017
 
 
5,253,318
 
 
$
8.28
 
 
 
3.89
 
Granted
 
 
-
 
 
 
-
 
 
 
-
 
Exercised
 
 
(42,343
)
 
 
4.28
 
 
 
-
 
Outstanding as of June 30, 2018
 
 
5,210,975
 
 
$
8.32
 
 
 
3.60
 
 
Upon the exercise of warrants, the Company will issue new shares of common stock.